JP4145230B2 - 神経障害の予防・治療剤 - Google Patents

神経障害の予防・治療剤 Download PDF

Info

Publication number
JP4145230B2
JP4145230B2 JP2003369875A JP2003369875A JP4145230B2 JP 4145230 B2 JP4145230 B2 JP 4145230B2 JP 2003369875 A JP2003369875 A JP 2003369875A JP 2003369875 A JP2003369875 A JP 2003369875A JP 4145230 B2 JP4145230 B2 JP 4145230B2
Authority
JP
Japan
Prior art keywords
group
optionally substituted
compound
alkyl
examples
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2003369875A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004168768A (ja
JP2004168768A5 (enExample
Inventor
祐 百瀬
望 坂井
毅志 前川
正聡 波佐間
透 河村
美佐代 瀬良
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical Co Ltd filed Critical Takeda Pharmaceutical Co Ltd
Priority to JP2003369875A priority Critical patent/JP4145230B2/ja
Publication of JP2004168768A publication Critical patent/JP2004168768A/ja
Publication of JP2004168768A5 publication Critical patent/JP2004168768A5/ja
Application granted granted Critical
Publication of JP4145230B2 publication Critical patent/JP4145230B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2003369875A 2002-11-01 2003-10-30 神経障害の予防・治療剤 Expired - Fee Related JP4145230B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2003369875A JP4145230B2 (ja) 2002-11-01 2003-10-30 神経障害の予防・治療剤

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002320153 2002-11-01
JP2003369875A JP4145230B2 (ja) 2002-11-01 2003-10-30 神経障害の予防・治療剤

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2008128851A Division JP2008231115A (ja) 2002-11-01 2008-05-15 神経障害の予防・治療剤

Publications (3)

Publication Number Publication Date
JP2004168768A JP2004168768A (ja) 2004-06-17
JP2004168768A5 JP2004168768A5 (enExample) 2008-07-03
JP4145230B2 true JP4145230B2 (ja) 2008-09-03

Family

ID=32715932

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003369875A Expired - Fee Related JP4145230B2 (ja) 2002-11-01 2003-10-30 神経障害の予防・治療剤

Country Status (1)

Country Link
JP (1) JP4145230B2 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602005027677D1 (de) * 2004-04-01 2011-06-09 Aventis Pharma Inc 1,3,4-oxadiazol-2-one als ppar-delta-modulatoren und deren verwendung
RU2365589C2 (ru) * 2004-04-01 2009-08-27 Авентис Фармасьютикалз Инк. 1,3,4-оксадиазол-2-оны в качестве модуляторов ppar-дельта, фармацевтические композиции на их основе и способ лечения
NZ552173A (en) * 2004-06-25 2010-07-30 Janssen Pharmaceutica Nv Quaternary salt CCR2 antagonists
EP2039779A1 (en) * 2006-07-19 2009-03-25 Takeda Pharmaceutical Company Limited Screening method
EP1939180A1 (en) * 2006-12-20 2008-07-02 sanofi-aventis Heteroarylacrylamides and their use as pharmaceuticals for the stimulation of the expression of endothelial NO synthase
CA2842364A1 (en) * 2011-07-29 2013-02-07 Karyopharm Therapeutics, Inc. Nuclear transport modulators and uses thereof
ES2954991T3 (es) 2011-07-29 2023-11-28 Karyopharm Therapeutics Inc Moduladores del transporte nuclear que contienen hidrazida y usos de los mismos
SMT202000347T1 (it) 2012-05-09 2020-07-08 Biogen Ma Inc Modulatori di trasporto nucleare e loro usi
WO2014144772A1 (en) 2013-03-15 2014-09-18 Karyopharm Therapeutics Inc. Methods of promoting wound healing using crm1 inhibitors
PL3010892T3 (pl) 2013-06-21 2019-07-31 Karyopharm Therapeutics, Inc. 1,2,4-triazole jako modulatory transportu jądrowego i ich zastosowania
CN111484483B (zh) 2014-08-15 2023-05-26 卡尔约药物治疗公司 赛灵克斯的多晶型物
EP3397634A1 (en) 2015-12-31 2018-11-07 Karyopharm Therapeutics, Inc. Nuclear transport modulators and uses thereof
EP3397633A1 (en) 2015-12-31 2018-11-07 Karyopharm Therapeutics, Inc. Nuclear transport modulators and uses thereof
US11602530B2 (en) 2016-11-28 2023-03-14 Biogen Ma Inc. CRM1 inhibitors for treating epilepsy
GB201901559D0 (en) * 2019-02-05 2019-03-27 Syngenta Crop Protection Ag Herbicidal compositions

Also Published As

Publication number Publication date
JP2004168768A (ja) 2004-06-17

Similar Documents

Publication Publication Date Title
US7423159B2 (en) Agent for preventing or treating neuropathy
US7368578B2 (en) Five-membered heterocyclic compounds
US7022725B2 (en) Isoxazole derivatives
US20050090534A1 (en) Azole compounds
JP4145230B2 (ja) 神経障害の予防・治療剤
US7179823B1 (en) 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity
JP5432890B2 (ja) 複素環誘導体及びその用途
US7223791B2 (en) Function regulator for retinoid relative receptor
US20040063775A1 (en) Five-membered heterocyclic alkanoic acid derivative
JPWO2006082952A1 (ja) アミド化合物
JP4213390B2 (ja) 縮合複素環化合物
JP4148672B2 (ja) イソオキサゾール誘導体
JP2003321460A (ja) アゾール化合物
JP2003081832A (ja) レチノイド関連受容体機能調節剤
JP2003261545A (ja) 神経栄養因子産生・分泌促進剤
JP4473698B2 (ja) ピリジン化合物
JP2004123732A (ja) ５員複素環化合物
KR20050044460A (ko) 피라졸 화합물의 제조 방법

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060420

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080515

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20080515

TRDD Decision of grant or rejection written
A975 Report on accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A971005

Effective date: 20080605

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20080610

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20080617

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110627

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110627

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110627

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110627

Year of fee payment: 3

LAPS Cancellation because of no payment of annual fees